Skip to main content
All stories

#Digital Health

12 articles on VentureBeast.Tech covering Digital Health. Strategic analysis and original reporting on digital health for builders and operators.

12 articles tagged #Digital Health.

Menopause Wearables' Evidence Gap: Sensors Yes, Trials No
Wellness11 min

Menopause Wearables' Evidence Gap: Sensors Yes, Trials No

Apple, Oura and Natural Cycles are adding perimenopause tracking, but a preprint review found only 4 of 80 menopause apps had published evaluations.

Medicare's $50 GLP-1 Bridge: What It Changes for Telehealth
HealthTech9 min

Medicare's $50 GLP-1 Bridge: What It Changes for Telehealth

Medicare now covers Wegovy, Foundayo and the Zepbound KwikPen at $50 a month for eligible enrollees. Telehealth loses the drug margin but keeps the care work.

Employer Health Navigation 2026: Transcarent, Included
HealthTech9 min

Employer Health Navigation 2026: Transcarent, Included

Transcarent ($3B valuation, 20M+ patients) bets on agentic AI navigation. Included Health bets on a copay-first alternative plan. Two paths, same problem.

Hospital-at-Home 2026: DispatchHealth, Biofourmis, CMS
HealthTech9 min

Hospital-at-Home 2026: DispatchHealth, Biofourmis, CMS

CMS made the hospital-at-home waiver permanent in Jan 2026. Medically Home merged into DispatchHealth. Here's the consolidated market and what changed.

Digital Pathology AI 2026: Paige, PathAI, Cancer Diagnosis
HealthTech9 min

Digital Pathology AI 2026: Paige, PathAI, Cancer Diagnosis

Roche is buying PathAI for up to $1.05B. Paige's AI raised prostate cancer detection sensitivity from 88.7% to 96.6%. Digital pathology just went mainstream.

AI Radiology 2026: FDA-Cleared Imaging Tools Explained
HealthTech10 min

AI Radiology 2026: FDA-Cleared Imaging Tools Explained

1,039 FDA-cleared AI radiology devices exist in 2026. Viz.ai's stroke triage has the strongest evidence; Aidoc just shipped the first foundation model.

Ambient Elder-Care 2026: Nobi, CarePredict, Cherish
HealthTech10 min

Ambient Elder-Care 2026: Nobi, CarePredict, Cherish

Nobi cut falls 31% across 80 UK care homes. CarePredict predicts UTIs from sleep patterns. Cherish does radar-only sensing. Ambient elder care just got real.

At-Home Genomics 2026: 23andMe, Nucleus, Genomelink
HealthTech10 min

At-Home Genomics 2026: 23andMe, Nucleus, Genomelink

23andMe restructured after Chapter 11. Nucleus pushes WGS upmarket. Genomelink wins on raw-data reanalysis. Pick your tier based on the actual use case.

GLP-1 Dispensing 2026: LillyDirect, Noom Med, Foundayo
HealthTech9 min

GLP-1 Dispensing 2026: LillyDirect, Noom Med, Foundayo

Eli Lilly's LillyDirect cash-pay platform and Foundayo oral GLP-1 launch bypassed insurers and PBMs. Noom Med partnered. Hims & Hers got squeezed.

Telehealth Shakeout: Hims, Ro, Lemonaid in 2026
HealthTech9 min

Telehealth Shakeout: Hims, Ro, Lemonaid in 2026

Hims & Hers hit $2.35B in 2025 — but the GLP-1 wave that drove growth triggered FDA, SEC, and Novo Nordisk legal exposure. The DTC market is consolidating.

Wearable ECG 2026: Apple, Withings, Samsung, Pixel Compared
HealthTech9 min

Wearable ECG 2026: Apple, Withings, Samsung, Pixel Compared

Four FDA-cleared wrist ECGs in 2026 — Apple Watch, Withings ScanWatch 2, Samsung Galaxy Watch, Pixel Watch. Accuracy ranges 84-98%. Here's how to pick.

Ambient Clinical AI 2026: DAX, Abridge, Suki Compared
HealthTech9 min

Ambient Clinical AI 2026: DAX, Abridge, Suki Compared

DAX Copilot owns enterprise. Abridge wins outcomes-evidence at Kaiser and Mayo. Suki serves independents. The 2026 ambient-AI market is settled.